Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10310 |
| Vaccine Name | HIL-214 (Hillivax) |
| Disease Name | Norovirus Infection |
| Disease Classification | Gastrointestinal |
| Virus Name | Norovirus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Virus like particle |
| Vaccine Status | Phase 2 |
| Manufacturer | Takeda Pharmaceutical Company Limited |
| Year of Manufacturing | 2012 |
| Manufacturing Country | USA |
| Age | 18 - 49 years |
| Dosage | 2 doses 28 days apart |
| Administration Route | Intramuscular |
| Adjuvant | MPL, aluminium hydroxide |
| Target Strain | GI.1 Norwalk VLP and GII.4 cVLP |
| Description | NA |
| Approving Organisation | NA |
| Collaborating Organisation | Frazier Healthcare Partners |
| Other Countries | NA |
| Trade Name | NA |
| PMID | NA |
| Clinical Trial ID | NCT01609257 |
| Reference Link | https://clinicaltrials.gov/ct2/show/NCT01609257 |
| Additional Links | NA |